NEWS DETAIL

Lonza is Recognised by Ethisphere as One of the World's Most Ethical Companies 2021

Basel, Switzerland, 23 February 2021 – Lonza has today been recognized as one of the World's Most Ethical Companies by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. The list distinguishes companies that influence the business community and societies around the world in order to drive positive change, and highlights companies working with partners and clients to do the right thing, by operating with integrity every day.

Lonza's designation as one of the World's Most Ethical Companies recognizes the company's high standards of corporate integrity and respect towards its customers, suppliers, business partners and other stakeholders. Lonza is one of just two companies headquartered in Switzerland to be included in the 2021 ranking. It is also one of only two companies to be named within the pharmaceuticals designation of the Ethisphere Institute ranking.

Structured by Ethisphere's proprietary Ethics Quotient®, the World's Most Ethical Companies assessment process includes more than 200 data points on culture, environmental and social practices, ethics and compliance activities, governance, diversity and initiatives to support a strong value chain. The process serves as an operating framework to capture and codify the leading practices of organizations across industries and around the world.

More information regarding the 2021 World’s Most Ethical Companies can be found here (https://ethisphere.com/2021-wme-announcement/).

About Lonza 

Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to prevent illness and enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. These enable our customers to commercialize their discoveries and innovations in the healthcare sector. 

Founded in 1897 in the Swiss Alps, today Lonza operates across three continents. With approximately 14,000 full-time employees, we are built from high-performing teams and of individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. 

The company generated sales of CHF 4.5 billion in 2020 with a CORE EBITDA of CHF 1.4 billion. Find out more at www.lonza.com 

Follow @Lonza on LinkedIn 
Follow @LonzaGroup on Twitter

About the Ethisphere Institute 

The Ethisphere® Institute is the global leader in defining and advancing the standards of ethical business practices that fuel corporate character, marketplace trust, and business success. Ethisphere has deep expertise in measuring and defining core ethics standards using data-driven insights that help companies enhance corporate character and measure and improve culture. Ethisphere honors superior achievement through its World’s Most Ethical Companies recognition program and provides a community of industry experts with the Business Ethics Leadership Alliance (BELA). More information about Ethisphere can be found at https://ethisphere.com.

Lonza Contact Details 

Victoria Morgan
Global Head of External Communications 
Lonza Group Ltd 
Tel 41 61 316 2283

Dirk Oehlers 
Investor Relations 
Lonza Group Ltd 
Tel 41 61 851 4927 

Additional Information and Disclaimer 

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual. 

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.